About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

FIGHT-RP 1 Extension Study | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingPhase 1NCT03999021

FIGHT-RP 1 Extension Study

Retinitis Pigmentosa (RP) is a devastating eye disease and at present there are no known treatment options that can alter the rate of vision loss and eventual blindness. In a series of studies in anim...

Lead sponsor: Johns Hopkins University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Johns Hopkins University

Collaborators

Zambon SpA

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age 18 years
•Patients diagnosed with RP
•Informed consent
•Authorization of use and disclosure of protected health information

Exclusion Criteria

•Patients with a concomitant ocular pathology that limits central macular function, including but not limited to: age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion
•Patients with an active ocular infection
•Patients with uncontrolled hypertension (defined as diastolic blood pressure \> 95 mm Hg or systolic blood pressure \> 160 mm Hg despite medical therapy)

Related studies

Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance

NCT07548944 · Retinitis Pigmentosa (RP), Usher Syndrome, and more

RECRUITINGPhase 3

A Study of AAV5-hRKp.RPGR for the Treatment of Japanese Participants With X-linked Retinitis Pigmentosa

NCT05926583 · Retinitis Pigmentosa

RECRUITINGPhase 2

A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa

NCT07174726 · X-Linked Retinitis Pigmentosa (XLRP)

Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital

NCT07292987 · Retinitis Pigmentosa (RP)

RECRUITINGPhase 1/2

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

NCT06789445 · Primary Photoreceptor Disease, Retinitis Pigmentosa (RP), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 9, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

PhasePHASE1

Enrollment30

Start dateJun 2019

Last updatedOct 9, 2025

Condition

Retinitis Pigmentosa

Locations shown

Wilmer Eye Institute at Johns Hopkins University

Baltimore, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 9, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions